Amgen

Anna S. Richo has been appointed senior vice president, Worldwide Compliance, Amgen. Ms. Richo will head the organization responsible for the company’s corporate compliance and business ethics programs. She will report to Amgen chairman and chief executive officer, Kevin Sharer.
   
Ms. Richo joined the company in 2003 and was most recently vice president, Law, responsible for worldwide management of all corporate litigation and law department operations. Prior to Amgen, she spent 12 years at Baxter Healthcare Corp. in roles of increasing responsibility in law, including vice president, Law, for Baxter’s BioScience Division. Also, Ms. Richo served on the board of directors of Cytyc Corp. and was a member of the audit and finance committees.
   
“As the compliance demands on biopharmaceutical companies are increasing, we want to ensure Amgen’s continued excellent performance in this area in the interests of patients and all our stakeholders,” said Mr. Sharer.